BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 32757648)

  • 1. Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis.
    Khandagale A; Åberg M; Wikström G; Bergström Lind S; Shevchenko G; Björklund E; Siegbahn A; Christersson C
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2293-2309. PubMed ID: 32757648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response.
    Khandagale A; Corcoran P; Nikpour M; Isaksson A; Wikström G; Siegbahn A; Christersson C
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicle cross-talk between pulmonary artery smooth muscle cells and endothelium during excessive TGF-β signalling: implications for PAH vascular remodelling.
    de la Cuesta F; Passalacqua I; Rodor J; Bhushan R; Denby L; Baker AH
    Cell Commun Signal; 2019 Nov; 17(1):143. PubMed ID: 31703702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles Derived from Endothelial Progenitor Cells Protect Human Glomerular Endothelial Cells and Podocytes from Complement- and Cytokine-Mediated Injury.
    Medica D; Franzin R; Stasi A; Castellano G; Migliori M; Panichi V; Figliolini F; Gesualdo L; Camussi G; Cantaluppi V
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bFGF overexpression adipose derived mesenchymal stem cells improved the survival of pulmonary arterial endothelial cells via PI3k/Akt signaling pathway.
    Wang P; Li J; Zhang C; Luo L; Ni S; Tang Z
    Int J Biochem Cell Biol; 2019 Aug; 113():87-94. PubMed ID: 31200125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance of claudin-5
    Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
    J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
    Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
    Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF.
    Wysoczynski M; Pathan A; Moore JB; Farid T; Kim J; Nasr M; Kang Y; Li H; Bolli R
    Stem Cell Rev Rep; 2019 Aug; 15(4):530-542. PubMed ID: 31102187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL
    Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Endothelium-Derived Wnt5a Is Associated With Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension.
    Yuan K; Shamskhou EA; Orcholski ME; Nathan A; Reddy S; Honda H; Mani V; Zeng Y; Ozen MO; Wang L; Demirci U; Tian W; Nicolls MR; de Jesus Perez VA
    Circulation; 2019 Apr; 139(14):1710-1724. PubMed ID: 30586764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-derived mesenchymal stromal cells improve hemodynamic function in pulmonary arterial hypertension: identification of microRNAs implicated in modulating endothelial function.
    Wang P; Zhang C; Li J; Luo L; Zhang S; Dong F; Tang Z; Ni S
    Cytotherapy; 2019 Apr; 21(4):416-427. PubMed ID: 30904330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles derived from human adipose-derived stem cells promote the exogenous angiogenesis of fat grafts via the let-7/AGO1/VEGF signalling pathway.
    Zhu Y; Zhang J; Hu X; Wang Z; Wu S; Yi Y
    Sci Rep; 2020 Mar; 10(1):5313. PubMed ID: 32210269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension.
    Winter MP; Sharma S; Altmann J; Seidl V; Panzenböck A; Alimohammadi A; Zelniker T; Redwan B; Nagel F; Santer D; Stieglbauer A; Podesser B; Sibilia M; Helbich T; Prager G; Ilhan-Mutlu A; Preusser M; Lang IM
    Basic Res Cardiol; 2020 Sep; 115(6):58. PubMed ID: 32880713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
    Zhao C; Le X; Li M; Hu Y; Li X; Chen Z; Hu G; Hu L; Li Q
    Respir Res; 2023 Nov; 24(1):289. PubMed ID: 37978368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension.
    Aldabbous L; Abdul-Salam V; McKinnon T; Duluc L; Pepke-Zaba J; Southwood M; Ainscough AJ; Hadinnapola C; Wilkins MR; Toshner M; Wojciak-Stothard B
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2078-87. PubMed ID: 27470511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.
    Voelkel NF; Gomez-Arroyo J
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):474-84. PubMed ID: 24932885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.